2.405
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
13.34%
2.667
|
2.353 | 2.077 | 2.024 | 3.464 |
|
|
11.00%
50.24
|
45.27 | 40.95 | 40.26 | 46.97 |
| Benefits Costs and Expenses |
100.00%
-
|
42.34 | 37.58 | - | - |
| Costs And Expenses |
18.66%
50.24
|
42.34 | 37.58 | 40.26 | 46.97 |
| Operating Income/Loss |
10.87%
-47.58
|
-42.91 | -38.88 | -38.24 | -43.50 |
| Nonoperating Income/Loss |
323.13%
-6.52
|
2.922 | 3.376 | 3.554 | 5.804 |
| Income/Loss From Continuing Operations Before Tax |
106.67%
2.667
|
-39.99 | -35.50 | 2.024 | -37.70 |
| Income/Loss From Continuing Operations After Tax |
35.28%
-54.10
|
-39.99 | -35.49 | -34.68 | -37.70 |
|
|
35.28%
-54.10
|
-39.99 | -35.49 | -34.68 | -37.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.38%
93.03
|
92.68 | 0.2831 | 90.46 | 90.34 |
| Diluted Average Shares |
0.38%
93.03
|
92.68 | 0.2831 | 90.46 | 90.34 |
| Basic Earnings Per Share |
34.88%
-0.58
|
-0.43 | -0.39 | -0.38 | -0.42 |
| Diluted Earnings Per Share |
34.88%
-0.58
|
-0.43 | -0.39 | -0.38 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):